all

MINNEAPOLIS, MN – (Sept. 14, 2019) – A comprehensive review of scientific evidence that analyzes the impact of low-carbohydrate and very-low-carbohydrate diets (including ketogenic diets) on cardiometabolic risk factors and body weight was released today by the National Lipid Association (NLA).

For patients 45 years of age or older with clinical ASCVD, or 50 years of age or older with type 2 diabetes requiring medication and > 1 additional risk factor, and fasting triglycerides 135-499 mg/dL on maximally tolerated statin, with or without exetimibe, treatment with icosapent ethyl is recommended for ASCVD risk reduction.

The NLA has released a scientific statement that analyzes the impact of low-carbohydrate and very-low-carbohydrate diets (including ketogenic diets) on cardiometabolic risk factors and body weight. The statement offers conclusions regarding the potential benefits, risks, and evidence gaps regarding low-carbohydrate and very-lowcarbohydrate diets and emphasizes the importance of an evidence-based cardioprotective dietary pattern and active lifestyle to promote cardiovascular health.